TFRC has been confirmed to be highly expressed in a variety of malignant tumors and provides a sufficient iron source to support the rapid proliferation of tumor cells by promoting iron endocytosis, which is also considered an important promoting factor for tumor cell growth and poor prognosis (16, 41, 42). The gene discussed is TFRC; the disease is neoplasm.